Key result
Beta-blockers are prescribed at discharge in ~68% of HFpEF hospitalizations, often without compelling indications.
Why the study?
Indications for β-blocker prescriptions among older adults hospitalized with HFpEF are not well understood.
Observational (n=254)
Yes
No takes yet. Share an insight, caveat, or question.
Beta-blocker prescriptions without compelling indications in HFpEF should not yet change practice; leaves open net benefit or harm in older adults.
Yum et al. (2019) conducted an observational in Heart failure with preserved ejection fraction (HFpEF) (n=254). Beta-blocker prescription at discharge was evaluated on Proportion of hospitalizations resulting in beta-blocker prescription at discharge. Beta-blockers were prescribed at discharge in 68% of HFpEF hospitalizations, with 40% of these prescriptions lacking a compelling indication such as arrhythmia or prior myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: